Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 146
1.
Nature ; 616(7956): 339-347, 2023 04.
Article En | MEDLINE | ID: mdl-36991126

There is a need to develop effective therapies for pancreatic ductal adenocarcinoma (PDA), a highly lethal malignancy with increasing incidence1 and poor prognosis2. Although targeting tumour metabolism has been the focus of intense investigation for more than a decade, tumour metabolic plasticity and high risk of toxicity have limited this anticancer strategy3,4. Here we use genetic and pharmacological approaches in human and mouse in vitro and in vivo models to show that PDA has a distinct dependence on de novo ornithine synthesis from glutamine. We find that this process, which is mediated through ornithine aminotransferase (OAT), supports polyamine synthesis and is required for tumour growth. This directional OAT activity is usually largely restricted to infancy and contrasts with the reliance of most adult normal tissues and other cancer types on arginine-derived ornithine for polyamine synthesis5,6. This dependency associates with arginine depletion in the PDA tumour microenvironment and is driven by mutant KRAS. Activated KRAS induces the expression of OAT and polyamine synthesis enzymes, leading to alterations in the transcriptome and open chromatin landscape in PDA tumour cells. The distinct dependence of PDA, but not normal tissue, on OAT-mediated de novo ornithine synthesis provides an attractive therapeutic window for treating patients with pancreatic cancer with minimal toxicity.


Ornithine-Oxo-Acid Transaminase , Pancreatic Neoplasms , Polyamines , Animals , Humans , Mice , Arginine/deficiency , Arginine/metabolism , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/metabolism , Ornithine/biosynthesis , Ornithine/metabolism , Ornithine-Oxo-Acid Transaminase/metabolism , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism , Polyamines/metabolism , Tumor Microenvironment
2.
Microbiol Spectr ; 10(3): e0082222, 2022 06 29.
Article En | MEDLINE | ID: mdl-35543513

In the yeast Saccharomyces cerevisiae, N-acetyl glutamate kinase (NAGK), which catalyzes the phosphorylation of N-acetyl glutamate to form N-acetyl glutamyl-5-phosphate, is one of the rate-limiting enzymes in the ornithine and arginine biosynthetic pathways. NAGK activity is strictly regulated via feedback inhibition by the end product, arginine. We previously reported that the Thr340Ile variant of NAGK was insensitive to arginine feedback inhibition and that the interaction between Lys336 and Thr340 in NAGK may be important for arginine recognition. In the present study, we demonstrated that amino acid changes of Thr340 to Ala, Leu, Arg, Glu, Ile, and Asn removed arginine feedback inhibition, although the Thr340Ser variant was subject to the feedback inhibition. Therefore, these results indicate that the arginine-binding cavity formed via the interaction between the carbonyl group in the main chain of Lys336 and the hydroxyl group in the side chain of the residue at position 340 is critical for arginine recognition of NAGK. In addition, we newly identified two mutations in the ARG5,6 gene encoding the Cys119Tyr or Val267Ala variant of NAGK of sake yeast mutants with intracellular ornithine accumulation. Although it is unlikely that Cys119 and Val267 are directly involved in arginine recognition, we found here that two variants of NAGK were insensitive to arginine feedback inhibition and contributed to high-level production of ornithine. Structural analysis of NAGK suggests that these two amino acid substitutions influence the sensitivity to Arg feedback inhibition through alterations in local conformation around each residue. IMPORTANCE Ornithine has a number of physiological benefits in humans. Thus, an Orn-rich alcoholic beverage is expected to relieve feelings of fatigue after drinking. In the yeast Saccharomyces cerevisiae, N-acetyl glutamate kinase (NAGK) encoded by the ARG5,6 gene catalyzes the second step in ornithine and arginine biosynthesis, and its activity is subjected to feedback inhibition by arginine. Here, we revealed a role of key residues in the formation of the arginine-binding cavity which is critical for arginine recognition of NAGK. In addition, we analyzed novel arginine feedback inhibition-insensitive variants of NAGK in sake yeast mutants with ornithine overproduction and proposed that the amino acid substitutions in the NAGK variants destabilize the arginine-binding cavity, leading to the lower sensitivity to arginine feedback inhibition of NAGK activity. These findings provide new insight into the allosteric regulation of NAGK activity and will help to construct superior industrial yeast strains for high-level production of ornithine.


Ornithine , Phosphotransferases (Carboxyl Group Acceptor) , Saccharomyces cerevisiae , Alcoholic Beverages , Arginine/chemistry , Feedback , Ornithine/biosynthesis , Phosphotransferases (Carboxyl Group Acceptor)/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics
3.
Toxins (Basel) ; 13(9)2021 09 07.
Article En | MEDLINE | ID: mdl-34564632

The bean (Phaseolus vulgaris) pathogen Pseudomonas syringae pv. phaseolicola NPS3121 synthesizes phaseolotoxin in a thermoregulated way, with optimum production at 18 °C. Gene PSPPH_4550 was previously shown to be thermoregulated and required for phaseolotoxin biosynthesis. Here, we established that PSPPH_4550 is part of a cluster of 16 genes, the Pbo cluster, included in a genomic island with a limited distribution in P. syringae and unrelated to the possession of the phaseolotoxin biosynthesis cluster. We identified typical non-ribosomal peptide synthetase, and polyketide synthetase domains in several of the pbo deduced products. RT-PCR and the analysis of polar mutants showed that the Pbo cluster is organized in four transcriptional units, including one monocistronic and three polycistronic. Operons pboA and pboO are both essential for phaseolotoxin biosynthesis, while pboK and pboJ only influence the amount of toxin produced. The three polycistronic units were transcribed at high levels at 18 °C but not at 28 °C, whereas gene pboJ was constitutively expressed. Together, our data suggest that the Pbo cluster synthesizes secondary metabolite(s), which could participate in the regulation of phaseolotoxin biosynthesis.


Multigene Family/genetics , Ornithine/analogs & derivatives , Pseudomonas syringae/genetics , Body Temperature Regulation , Ornithine/biosynthesis , Pseudomonas syringae/metabolism
4.
Cell Death Differ ; 28(1): 303-319, 2021 01.
Article En | MEDLINE | ID: mdl-32770108

Pyrroline-5-carboxylate synthase (P5CS) catalyzes the synthesis of pyrroline-5-carboxylate (P5C), a key precursor for the synthesis of proline and ornithine. P5CS malfunction leads to multiple human diseases; however, the molecular mechanism underlying these diseases is unknown. We found that P5CS localizes in mitochondria in rod- and ring-like patterns but diffuses inside the mitochondria upon cellular starvation or exposure to oxidizing agents. Some of the human disease-related mutant forms of P5CS also exhibit diffused distribution. Multimerization (but not the catalytic activity) of P5CS regulates its localization. P5CS mutant cells have a reduced proliferation rate and are sensitive to cellular stresses. Flies lacking P5CS have reduced eclosion rates. Lipid droplets accumulate in the eyes of the newly eclosed P5CS mutant flies, which degenerate with aging. The loss of P5CS in cells leads to abnormal purine metabolism and lipid-droplet accumulation. The reduced lipid-droplet consumption is likely due to decreased expression of the fatty acid transporter, CPT1, and few ß-oxidation-related genes following P5CS knockdown. Surprisingly, we found that P5CS is required for mitochondrial respiratory complex organization and that the respiration defects in P5CS knockout cells likely contribute to the metabolic defects in purine synthesis and lipid consumption. This study links amino acid synthesis with mitochondrial respiration and other key metabolic processes, whose imbalance might contribute to P5CS-related disease conditions.


Mitochondria/metabolism , Ornithine-Oxo-Acid Transaminase/metabolism , Animals , Drosophila , HeLa Cells , Humans , Mitochondrial Dynamics , Ornithine/biosynthesis , Ornithine-Oxo-Acid Transaminase/genetics , Proline/biosynthesis
5.
ACS Synth Biol ; 9(7): 1855-1863, 2020 07 17.
Article En | MEDLINE | ID: mdl-32551572

l-Proline takes a significant role in the pharmaceutical and chemical industries as well as graziery. Typical biosynthesis of l-proline is from l-glutamate, involving three enzyme reactions as well as a spontaneous cyclization. Alternatively, l-proline can be also synthesized in l-ornithine and/or l-arginine producing strains by an ornithine aminotransferase (OCD). In this study, a strategy of directed evolution combining rare codon selection and pEvolvR was developed to screen OCD with high catalytic efficiency, improving l-proline production from l-arginine chassis cells. The mutations were generated by CRISPR-assisted DNA polymerases and were screened by growth-coupled rare codon selection system. OCDK205G/M86K/T162A from Pseudomonas putida was identified with 2.85-fold increase in catalytic efficiency for the synthesis of l-proline. Furthermore, we designed and optimized RBS for the BaargI and Ppocd coupling cascade using RedLibs, as well as sRNA inhibition of argF to moderate l-proline biosynthesis in l-arginine overproducing Corynebacterium crenatum. The strain PS6 with best performance reached 15.3 g/L l-proline in the shake flask and showed a titer of 38.4 g/L in a 5 L fermenter with relatively low concentration of residual l-ornithine and/or l-arginine.


Corynebacterium/enzymology , Corynebacterium/genetics , Directed Molecular Evolution/methods , Ornithine-Oxo-Acid Transaminase/metabolism , Proline/biosynthesis , Pseudomonas putida/enzymology , Pseudomonas putida/genetics , Ammonia-Lyases , Arginine/biosynthesis , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biocatalysis , Clustered Regularly Interspaced Short Palindromic Repeats/genetics , Codon , DNA-Directed DNA Polymerase , Metabolic Engineering/methods , Mutant Proteins/metabolism , Mutation , Ornithine/biosynthesis , Ornithine-Oxo-Acid Transaminase/genetics , Plasmids/genetics
6.
Appl Microbiol Biotechnol ; 104(15): 6635-6646, 2020 Aug.
Article En | MEDLINE | ID: mdl-32529376

This study aims to use neutral pH optimum arginase as the catalyst for high-efficiency L-ornithine production. Sulfobacillus acidophilus arginase was firstly cloned and overexpressed in Escherichia coli. The purified enzyme was obtained, and the molecular mass determination showed that this arginase was a hexamer. S. acidophilus arginase possessed similarities with the other arginases such as the conserved sequences, purification behavior, and the necessity for Mn2+ as a cofactor. The maximum enzyme activity was obtained at pH 7.5 and 70 °C. Thermostability and pH stability analysis showed that the arginase was stable at 30-60 °C and pH 7.0-8.5, respectively. The kinetic parameters suggested that S. acidophilus arginase could efficiently hydrolyze L-arginine. Bioconversion with this neutral pH optimum arginase had the advantages of avoiding producing by-product, high molar yield, and high-level production of L-ornithine. When the bioconversion was performed with a fed-batch strategy and a coupled-enzyme system involving S. acidophilus arginase and Jack bean urease, the final production of 2.87 mol/L was obtained with only 1.72 mmol/L L-arginine residue, and the molar yield was 99.9%. The highest production record suggests that S. acidophilus arginase has a great prospect in industrial L-ornithine production.


Arginase/metabolism , Clostridiales/enzymology , Ornithine/biosynthesis , Temperature , Arginase/genetics , Arginine/metabolism , Biocatalysis , Clostridiales/genetics , Enzyme Stability , Escherichia coli/genetics , Escherichia coli/metabolism , Hydrogen-Ion Concentration , Kinetics , Manganese/metabolism , Substrate Specificity
7.
Appl Biochem Biotechnol ; 191(3): 955-967, 2020 Jul.
Article En | MEDLINE | ID: mdl-31950445

Here, Corynebacterium glutamicum SNK118 was metabolically engineered for L-ornithine production through CRISPR-Cpf1-based genome manipulation and plasmid-based heterologous overexpression. Genes argF, argR, and ncgl2228 were deleted to block the degradation of L-ornithine, eliminate the global transcriptional repression, and alleviate the competitive branch pathway, respectively. Overexpression of CsgapC (NADP-dependent glyceraldehyde 3-phosphate dehydrogenases gene from Clostridium saccharobutylicum DSM 13864) and BsrocG (NADH-dependent glutamate dehydrogenase gene from Bacillus subtilis HB-1) resulted markedly increased ornithine biosynthesis. Eventually, the engineered strain KBJ11 (SNK118ΔargRΔargFΔncgl2228/pXMJ19-CsgapC-BsrocG) was constructed for L-ornithine overproduction. In fed-batch fermentation, L-ornithine of 88.26 g/L with productivity of 1.23 g/L/h (over 72 h) and yield of 0.414 g/g glucose was achieved by strain KBJ11 in a 10-L bioreactor. Our result represents the highest titer and yield of L-ornithine production by microbial fermentation. This study suggests that heterologous expression of CsgapC and BsrocG could promote L-ornithine production by C. glutamicum strains.


CRISPR-Cas Systems , Corynebacterium glutamicum/genetics , Glutamate Synthase (NADH)/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Ornithine/biosynthesis , Arginine/metabolism , Bioreactors , Citrulline/metabolism , Corynebacterium glutamicum/enzymology , Escherichia coli/genetics , Escherichia coli/metabolism , Fermentation , Genome, Bacterial , Glucose/metabolism , Glycolysis , Industrial Microbiology , Metabolic Engineering , NADP/metabolism , Plasmids/genetics , Recombinant Proteins/metabolism , Transcription, Genetic
8.
Microb Cell Fact ; 19(1): 2, 2020 Jan 06.
Article En | MEDLINE | ID: mdl-31906967

BACKGROUND: L-ornithine is a valuable amino acid with a wide range of applications in the pharmaceutical and food industries. However, the production of L-ornithine by fermentation cannot compete with other methods, because of the low titers produced with this technique. Development of fermentation techniques that result in a high yield of L-ornithine and efficient strategies for improving L-ornithine production are essential. RESULTS: This study demonstrates that tween 40, a surfactant promoter of the production of glutamate and arginine, improves L-ornithine production titers in engineered C. glutamicum S9114. The intracellular metabolism under tween 40 triggered fermentation conditions was explored using a quantitative proteomic approach, identifying 48 up-regulated and 132 down-regulated proteins when compared with the control. Numerous proteins were identified as membrane proteins or functional proteins involved in the biosynthesis of the cell wall. Modulation of those genes revealed that the overexpression of CgS9114_09558 and the deletion of CgS9114_13845, CgS9114_02593, and CgS9114_02058 improved the production of L-ornithine in the engineered strain of C. glutamicum Orn8. The final strain with all the exploratory metabolic engineering manipulations produced 25.46 g/L of L-ornithine, and a yield of 0.303 g L-ornithine per g glucose, which was 30.6% higher than that produced by the original strain (19.5 g/L). CONCLUSION: These results clearly demonstrate the positive effect of tween 40 addition on L-ornithine accumulation. Proteome analysis was performed to examine the impact of tween 40 addition on the physiological changes in C. glutamicum Orn8 and the results showed several promising modulation targets for developing L-ornithine-producing strains.


Corynebacterium glutamicum/metabolism , Metabolic Engineering/methods , Microorganisms, Genetically-Modified/metabolism , Ornithine/biosynthesis , Polysorbates , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Corynebacterium glutamicum/genetics , Genes, Bacterial , Genome, Bacterial , Proteome/metabolism , Proteomics
9.
Biol Pharm Bull ; 42(9): 1581-1589, 2019.
Article En | MEDLINE | ID: mdl-31474718

As a bacterium used in industry for production of several amino acids, an endotoxin-free Corynebacterium (C.) glutamicum is well known. However, it is also true that the endotoxin-producing other Corynebacterium species is present. An aim of this study is to obtain a lactic acid bacterium (LAB) that produces ornithine and citrulline at high levels. We successfully isolated a strain, designated K-28, and identified it as Weissella (W.) confusa. The production of ornithine and citrulline by K-28 was 18 ± 1 and 10 ± 2 g/L, respectively, with a 100 ± 9% conversion rate when arginine was continuously fed into a jar fermenter. Although the ornithine high production using C. glutamicum is industrially present, the strains have been genetically modified. In that connection, the wild-type of C. glutamicum produces only 0.5 g/L ornithine, indicating that W. confusa K-28 is superior to C. glutamicum to use a probiotic microorganism. We confirmed that W. confusa K-28 harbors an arginine deiminase (ADI) gene cluster, wkaABDCR. The production of ornithine and the expression of these genes significantly decreased under the aerobic condition rather than anaerobic one. The expression level of the five genes did not differ with or without arginine, suggesting that the production of amino acids in the K-28 strain was not induced by exogenous arginine.


Citrulline/biosynthesis , Flowers/microbiology , Ornithine/biosynthesis , Senna Plant/microbiology , Weissella/metabolism , Animals , Citrulline/toxicity , Male , Ornithine/toxicity , Probiotics , Rats, Sprague-Dawley , Rats, Wistar , Toxicity Tests, Acute , Weissella/isolation & purification
10.
Commun Biol ; 2: 171, 2019.
Article En | MEDLINE | ID: mdl-31098404

Gut mucosal layers are crucial in maintaining the gut barrier function. Gut microbiota regulate homeostasis of gut mucosal layer via gut immune cells such as RORγt (+) IL-22(+) ILC3 cells, which can influence the proliferation of mucosal cells and the production of mucin. However, it is unclear how gut microbiota execute this regulation. Here we show that lactobacilli promote gut mucosal formation by producing L-Ornithine from arginine. L-Ornithine increases the level of aryl hydrocarbon receptor ligand L-kynurenine produced from tryptophan metabolism in gut epithelial cells, which in turn increases RORγt (+)IL-22(+) ILC3 cells. Human REG3A transgenic mice show an increased proportion of L-Ornithine producing lactobacilli in the gut contents, suggesting that gut epithelial REG3A favors the expansion of L-Ornithine producing lactobacilli. Our study implicates the importance of a crosstalk between arginine metabolism in Lactobacilli and tryptophan metabolism in gut epithelial cells in maintaining gut barrier.


Gastrointestinal Microbiome/immunology , Gastrointestinal Microbiome/physiology , Intestinal Mucosa/immunology , Intestinal Mucosa/microbiology , Lactobacillus/immunology , Ornithine/biosynthesis , Animals , Basic Helix-Loop-Helix Transcription Factors/metabolism , Epithelial Cells/immunology , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Female , Germ-Free Life , Homeostasis , Humans , Intestinal Mucosa/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Mucus/metabolism , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Pancreatitis-Associated Proteins/genetics , Pancreatitis-Associated Proteins/metabolism , Receptors, Aryl Hydrocarbon/metabolism
11.
PLoS One ; 14(1): e0210342, 2019.
Article En | MEDLINE | ID: mdl-30650113

The non-proteinogenic amino acid ornithine links several stress response pathways. From a previous study we know that ornithine accumulates in response to low CO2. To investigate ornithine accumulation in plants, we shifted plants to either low CO2 or low light. Both conditions increased carbon limitation, but only low CO2 also increased the rate of photorespiration. Changes in metabolite profiles of light- and CO2-limited plants were quite similar. Several amino acids that are known markers of senescence accumulated strongly under both conditions. However, urea cycle intermediates respond differently between the two treatments. While the levels of both ornithine and citrulline were much higher in plants shifted to 100 ppm CO2 compared to those kept in 400 ppm CO2, their metabolite abundance did not significantly change in response to a light limitation. Furthermore, both ornithine and citrulline accumulation is independent from sugar starvation. Exogenous supplied sugar did not significantly change the accumulation of the two metabolites in low CO2-stressed plants, while the accumulation of other amino acids was reduced by about 50%. Gene expression measurements showed a reduction of the entire arginine biosynthetic pathway in response to low CO2. Genes in both proline biosynthesis and degradation were induced. Hence, proline did not accumulate in response to low CO2 like observed for many other stresses. We propose that excess of nitrogen re-fixed during photorespiration can be alternatively stored in ornithine and citrulline under low CO2 conditions. Furthermore, ornithine is converted to pyrroline-5-carboxylate by the action of δOAT.


Arabidopsis/metabolism , Carbon Dioxide/metabolism , Urea/metabolism , Arabidopsis/genetics , Arabidopsis/radiation effects , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Arginine/biosynthesis , Biosynthetic Pathways/genetics , Citrulline/metabolism , Gene Expression Regulation, Plant , Genes, Plant , Light , Models, Biological , Mutation , Ornithine/biosynthesis , Ornithine/metabolism , Ornithine-Oxo-Acid Transaminase/genetics , Ornithine-Oxo-Acid Transaminase/metabolism , Proline/biosynthesis , Proline/metabolism , Pyrroles/metabolism , RNA, Plant/genetics , Stress, Physiological , Sucrose/metabolism
12.
Environ Microbiol ; 20(11): 3992-4008, 2018 11.
Article En | MEDLINE | ID: mdl-30252196

Ornithine lipids (OLs) are bacteria-specific lipids that are found in the outer membrane of Gram (-) bacteria and increase as surrogates of phospholipids under phosphate-limited environmental conditions. We investigated the effects of OL increase in bacterial membranes on pathogen virulence and the host immune response. In Pseudomonas aeruginosa, we increased OL levels in membranes by overexpressing the OL-synthesizing operon (olsBA). These increases changed the bacterial surface charge and hydrophobicity, which reduced bacterial susceptibility to antibiotics and antimicrobial peptides (AMPs), interfered with the binding of macrophages to bacterial cells and enhanced bacterial biofilm formation. When grown under low phosphate conditions, P. aeruginosa became more persistent in the treatment of antibiotics and AMPs in an olsBA-dependent manner. While OLs increased persistence, they attenuated P. aeruginosa virulence; in host cells, they reduced the production of inflammatory factors (iNOS, COX-2, PGE2 and nitric oxide) and increased intracellular Ca2+ release. Exogenously added OL had similar effects on P. aeruginosa and host cells. Our results suggest that bacterial OL plays important roles in bacteria-host interaction in a way that enhances bacterial persistence and develops chronic adaptation to infection.


Lipids/physiology , Ornithine/analogs & derivatives , Pseudomonas aeruginosa/physiology , Animals , Anti-Bacterial Agents/pharmacology , Caenorhabditis elegans/microbiology , Drug Resistance, Bacterial , Host-Pathogen Interactions , Membrane Lipids/physiology , Ornithine/biosynthesis , Ornithine/physiology , Phosphates/metabolism , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/pathogenicity , Tenebrio/microbiology , Virulence
13.
J Ind Microbiol Biotechnol ; 45(6): 393-404, 2018 Jun.
Article En | MEDLINE | ID: mdl-29728854

L-Ornithine is a non-protein amino acid with extensive applications in the food and pharmaceutical industries. In this study, we performed metabolic pathway engineering of an L-arginine hyper-producing strain of Corynebacterium crenatum for L-ornithine production. First, we amplified the L-ornithine biosynthetic pathway flux by blocking the competing branch of the pathway. To enhance L-ornithine synthesis, we performed site-directed mutagenesis of the ornithine-binding sites to solve the problem of L-ornithine feedback inhibition for ornithine acetyltransferase. Alternatively, the genes argA from Escherichia coli and argE from Serratia marcescens, encoding the enzymes N-acetyl glutamate synthase and N-acetyl-L-ornithine deacetylase, respectively, were introduced into Corynebacterium crenatum to mimic the linear pathway of L-ornithine biosynthesis. Fermentation of the resulting strain in a 5-L bioreactor allowed a dramatically increased production of L-ornithine, 40.4 g/L, with an overall productivity of 0.673 g/L/h over 60 h. This demonstrates that an increased level of transacetylation is beneficial for L-ornithine biosynthesis.


Corynebacterium/metabolism , Metabolic Engineering , Ornithine/biosynthesis , Acetylation , Arginine/metabolism , Bacterial Proteins/genetics , Bioreactors , Biosynthetic Pathways , Corynebacterium/genetics , Escherichia coli/genetics , Fermentation , Industrial Microbiology , Mutagenesis, Site-Directed , Mutation , Serratia marcescens/metabolism
14.
Nat Commun ; 9(1): 550, 2018 02 07.
Article En | MEDLINE | ID: mdl-29416041

Amino acids play essential roles in cell biology as regulators of metabolic pathways. Arginine in particular is a major signalling molecule inside the cell, being a precursor for both l-ornithine and nitric oxide (NO) synthesis and a key regulator of the mTORC1 pathway. In mammals, cellular arginine availability is determined by members of the solute carrier (SLC) 7 family of cationic amino acid transporters. Whereas CAT-1 functions to supply cationic amino acids for cellular metabolism, CAT-2A and -2B are required for macrophage activation and play important roles in regulating inflammation. Here, we present the crystal structure of a close homologue of the mammalian CAT transporters that reveals how these proteins specifically recognise arginine. Our structural and functional data provide a model for cationic amino acid transport in mammalian cells and reveals mechanistic insights into proton-coupled, sodium-independent amino acid transport in the wider APC superfamily.


Amino Acid Transport Systems, Basic/chemistry , Amino Acid Transport Systems, Basic/metabolism , Animals , Arginine/metabolism , Crystallization , Crystallography, X-Ray , Nitric Oxide/biosynthesis , Ornithine/biosynthesis
15.
J Ind Microbiol Biotechnol ; 45(2): 123-139, 2018 Feb.
Article En | MEDLINE | ID: mdl-29344811

Putrescine is widely used in the industrial production of bioplastics, pharmaceuticals, agrochemicals, and surfactants. Because the highest titer of putrescine is much lower than that of its precursor L-ornithine reported in microorganisms to date, further work is needed to increase putrescine production in Corynebacterium glutamicum. We first compared 7 ornithine decarboxylase genes and found that the Enterobacter cloacae ornithine decarboxylase gene speC1 was most suitable for putrescine production in C. glutamicum. Increasing NADPH availability and blocking putrescine oxidation and acetylation were chosen as targets for metabolic engineering. The putrescine producer C. glutamicum PUT4 was first constructed by deleting puo, butA and snaA genes, and replacing the fabG gene with E. cloacae speC1. After adaptive evolution with C. glutamicum PUT4, the evolved strain C. glutamicum PUT-ALE, which produced an 96% higher amount of putrescine compared to the parent strain, was obtained. The whole genome resequencing indicates that the SNPs located in the odhA coding region may be associated with putrescine production. The comparative proteomic analysis reveals that the pentose phosphate and anaplerotic pathway, the glyoxylate cycle, and the ornithine biosynthetic pathway were upregulated in the evolved strain C. glutamicum PUT-ALE. The aspartate family, aromatic, and branched chain amino acid and fatty acid biosynthetic pathways were also observed to be downregulated in C. glutamicum PUT-ALE. Reducing OdhA activity by replacing the odhA native start codon GTG with TTG and overexpression of cgmA or pyc458 further improved putrescine production. Repressing the carB, ilvH, ilvB and aroE expression via CRISPRi also increased putrescine production by 5, 9, 16 and 19%, respectively.


Corynebacterium glutamicum/genetics , Putrescine/biosynthesis , Biosynthetic Pathways , Corynebacterium glutamicum/metabolism , Enterobacter cloacae/enzymology , Gene Deletion , Metabolic Engineering , NADP/metabolism , Ornithine/biosynthesis , Ornithine Decarboxylase/genetics , Polymorphism, Single Nucleotide , Proteomics
16.
Microb Cell Fact ; 16(1): 158, 2017 Sep 22.
Article En | MEDLINE | ID: mdl-28938890

BACKGROUND: L-Ornithine is a non-protein amino acid with extensive applications in medicine and the food industry. Currently, L-ornithine production is based on microbial fermentation, and few microbes are used for producing L-ornithine owing to unsatisfactory production titer. RESULTS: In this study, Corynebacterium glutamicum S9114, a high glutamate-producing strain, was developed for L-ornithine production by pathway engineering. First, argF was deleted to block L-ornithine to citrulline conversion. To improve L-ornithine production, ncgl1221 encoding glutamate transporter, argR encoding arginine repressor, and putP encoding proline transporter were disrupted. This base strain was further engineered by attenuating oxoglutarate dehydrogenase to increase L-ornithine production. Plasmid-based overexpression of argCJBD operon and lysine/arginine transport protein LysE was tested to strengthen L-ornithine synthesis and transportation. This resulted in efficient L-ornithine production at a titer of 18.4 g/L. CONCLUSION: These results demonstrate the potential of Corynebacterium glutamicum S9114 for efficient L-ornithine production and provide new targets for strain development.


Corynebacterium glutamicum/genetics , Corynebacterium glutamicum/metabolism , Ornithine/biosynthesis , Amino Acid Transport Systems/genetics , Amino Acid Transport Systems/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Fermentation , Glutamic Acid/metabolism , Metabolic Engineering , Operon , Plasmids/genetics , Plasmids/metabolism
17.
PLoS One ; 12(6): e0178441, 2017.
Article En | MEDLINE | ID: mdl-28570637

Pseudomonas syringae pv. phaseolicola produces phaseolotoxin in a temperature dependent manner, being optimally synthesized between 18°C and 20°C, while no detectable amounts are present above 28°C. The Pht cluster, involved in the biosynthesis of phaseolotoxin, contains 23 genes that are organized in five transcriptional units. The function of most of the genes from the Pht cluster is still unknown and little information about the regulatory circuitry leading to expression of these genes has been reported. The purpose of the present study was to investigate the participation of pht genes in the regulation of the operons coded into the Pht cluster. We conducted Northern blot, uidA fusions and reverse transcription-PCR assays of pht genes in several mutants unable to produce phaseolotoxin. This allowed us to determine that, in P. syringae pv. phaseolicola NPS3121, genes phtABC are essential to prevent their own expression at 28°C, a temperature at which no detectable amounts of the toxin are present. We obtained evidence that the phtABC genes also participate in the regulation of the phtD, phtM and phtL operons. According to our results, we propose that PhtABC and other Pht product activities could be involved in the synthesis of the sulfodiaminophosphinyl moiety of phaseolotoxin, which indirectly could be involved in the transcriptional regulation of the phtA operon.


Genes, Plant , Ornithine/analogs & derivatives , Pseudomonas syringae/metabolism , Temperature , Mutation , Ornithine/biosynthesis , Pseudomonas syringae/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic
18.
Plant Cell Physiol ; 58(1): 130-144, 2017 01 01.
Article En | MEDLINE | ID: mdl-28064246

Arabidopsis thaliana At4g17830 codes for a protein showing sequence similarity with the Escherichia coli N-acetylornithine deacetylase (EcArgE), an enzyme implicated in the linear ornithine (Orn) biosynthetic pathway. In plants, N-acetylornithine deacetylase (NAOD) activity has yet to be demonstrated; however, At4g17830-silenced and mutant (atnaod) plants display an impaired reproductive phenotype and altered foliar levels of Orn and polyamines (PAs). Here, we showed the direct connection between At4g17830 function and Orn biosynthesis, demonstrating biochemically that At4g17830 codes for a NAOD. These results are the first experimental proof that Orn can be produced in Arabidopsis via a linear pathway. In this study, to identify the role of AtNAOD in reproductive organs, we carried out a transcriptomic analysis on atnaod mutant and wild-type flowers. In the atnaod mutant, the most relevant effects were the reduced expression of cysteine-rich peptide-coding genes, known to regulate male-female cross-talk during reproduction, and variation in the expression of genes involved in nitrogen:carbon (N:C) status. The atnaod mutant also exhibited increased levels of sucrose and altered sensitivity to glucose. We hypothesize that AtNAOD participates in Orn and PA homeostasis, contributing to maintain an optimal N:C balance during reproductive development.


Amidohydrolases/metabolism , Arabidopsis Proteins/metabolism , Arabidopsis/metabolism , Ornithine/biosynthesis , Polyamines/metabolism , Amidohydrolases/chemistry , Amidohydrolases/genetics , Amino Acid Sequence , Arabidopsis/genetics , Arabidopsis Proteins/classification , Arabidopsis Proteins/genetics , Biocatalysis , Biosynthetic Pathways/genetics , Electrophoresis, Polyacrylamide Gel , Flowers/genetics , Flowers/metabolism , Gene Expression Profiling/methods , Gene Expression Regulation, Plant , Hydrolysis , Kinetics , Models, Chemical , Models, Molecular , Molecular Structure , Mutation , Ornithine/analogs & derivatives , Ornithine/chemistry , Ornithine/metabolism , Phylogeny , Protein Domains , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid
19.
Appl Environ Microbiol ; 82(20): 6167-6173, 2016 10 15.
Article En | MEDLINE | ID: mdl-27520810

Mycosporine-like amino acids (MAAs) are an important class of secondary metabolites known for their protection against UV radiation and other stress factors. Cyanobacteria produce a variety of MAAs, including shinorine, the active ingredient in many sunscreen creams. Bioinformatic analysis of the genome of the soil-dwelling cyanobacterium Cylindrospermum stagnale PCC 7417 revealed a new gene cluster with homology to MAA synthase from Nostoc punctiforme This newly identified gene cluster is unusual because it has five biosynthesis genes (mylA to mylE), compared to the four found in other MAA gene clusters. Heterologous expression of mylA to mylE in Escherichia coli resulted in the production of mycosporine-lysine and the novel compound mycosporine-ornithine. To our knowledge, this is the first time these compounds have been heterologously produced in E. coli and structurally characterized via direct spectral guidance. This study offers insight into the diversity, biosynthesis, and structure of cyanobacterial MAAs and highlights their amenability to heterologous production methods. IMPORTANCE: Mycosporine-like amino acids (MAAs) are significant from an environmental microbiological perspective as they offer microbes protection against a variety of stress factors, including UV radiation. The heterologous expression of MAAs in E. coli is also significant from a biotechnological perspective as MAAs are the active ingredient in next-generation sunscreens.


Amino Acids/biosynthesis , Cyanobacteria/metabolism , Cyclohexanols/metabolism , Escherichia coli/metabolism , Lysine/biosynthesis , Ornithine/biosynthesis , Amino Acids/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cyanobacteria/genetics , Cyclohexanols/chemistry , Escherichia coli/genetics , Lysine/chemistry , Ornithine/chemistry
20.
Life Sci ; 146: 73-80, 2016 Feb 01.
Article En | MEDLINE | ID: mdl-26773858

AIMS: Hyperphosphatemia is associated with accelerated vascular endothelial dysfunction in patients with chronic kidney disease (CKD). The purpose of this study is to investigate the molecular mechanisms underlying hyperphosphatemia-caused endothelial dysfunction. MAIN METHODS: The metabolic fingerprinting of human umbilical vein endothelial cells (HUVECs) subjected to hyperphosphatemia was characterized using an integrated metabolomics approach. HUVECs cultured in physiologically simulated hyperphosphatemia with or without phosphonoformic acid, a sodium-dependent phosphate transporter inhibitor (N=6) were collected for metabolomics analysis. Multivariate principle component analysis and partial least squares discriminant analysis were applied to analyze the metabolic data. The key metabolites were confirmed by quantitative analysis using liquid chromatography coupled with tandem mass spectrometer (LC-MS/MS). KEY FINDINGS: 36 metabolites were significantly altered in HUVECs following the challenges of hyperphosphatemia mimic, involving several metabolic pathways (all P<0.05). Among them, ornithine increased significantly in the HUVECs mediated by hyperphosphatemia mimic, and its levels positively correlated with cell apoptosis rate (r=0.674, P=0.002), and several additional metabolites in multiple metabolic pathways. The changes in the levels of ornithine and other several metabolites were supported by subsequent quantitative analyses using LC-MS/MS. Further study demonstrated that the increase in ornithine level may result from the increased expression of arginase 2 in HUVECs, which mediates the hydrolysis of arginine to form ornithine. SIGNIFICANCE: This is the first study demonstrating ornithine a key molecule mediating hyperphosphatemia-induced apoptosis of ECs. Arginase 2 may be a therapeutic target for hyperphosphatemia-associated cardiovascular events.


Apoptosis , Human Umbilical Vein Endothelial Cells/pathology , Hyperphosphatemia/physiopathology , Metabolomics , Ornithine/metabolism , Arginase/metabolism , Arginine/metabolism , Foscarnet/pharmacology , Humans , Hyperphosphatemia/pathology , Metabolic Networks and Pathways/drug effects , Ornithine/biosynthesis , Ornithine/pharmacology , Ornithine Decarboxylase/metabolism , Phosphate Transport Proteins/antagonists & inhibitors , Phosphates/metabolism , Phosphates/pharmacology
...